Company: PSTV
Filing Date: 2025-03-14
Form Type: PRE 14A
Source: 0001140361-25-008857
Chunk: 34

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-03-14
Form: PRE 14A
Chunk 34
---
 of their ownership of the May 2024 Warrants and the benefits conferred by extending the term of the May 2024 Warrants and potential economic gain received upon exercise thereof.

<div align='center'>20</div>

TABLE OF CONTENTS

The following table contains information relating to the ownership of May 2024 Warrants owned by our executive officers and directors, based on information as of March 14, 2025. As of that date, there were 3,093,708 May 2024 Warrants issued and outstanding.

| Name of Beneficial Owner(1) |     | Number of Shares of 
        Common Stock 
 Underlying May 2024 
      Warrants Owned |     | Percent Ownership of   
 Total Number of        
 Shares of Common Stock 
 Underlying Outstanding 
 May 2024 Warrants      |
| Marc H. Hedrick, M.D.(1)    |     |              12,255 |     | *                      |
| Andrew Sims(2)              |     |               4,902 |     | *                      |
| Howard Clowes(3)            |     |               9,804 |     | *                      |
| Richard J. Hawkins(4)       |     |               4,902 |     | *                      |
| Greg Petersen(5)            |     |              12,255 |     | *                      |
| Robert P. Lenk, PhD(6)      |     |               4,167 |     | *                      |

| * | Less than 1%. |

| (1) | Dr. Hedrick is the President, Chief Executive Officer and a director of the Company. |

| (2) | Mr. Sims is the Chief Financial Officer of the Company. |

| (3) | Mr. Clowes is a director of the Company. |

| (4) | Mr. Hawkins is the Chairman of the Board of the Company. |

| (5) | Mr. Petersen is a director of the Company. |

| (6) | Dr. Lenk is a director of the Company. |

Required Vote of Stockholders Approval of Proposal No. 4 requires the affirmative vote of a majority of the Common Stock having voting power present, virtually or by proxy. Abstentions are considered shares present and entitled to vote and thus will have the effect of a vote “AGAINST” this proposal. Broker non-votes will have no effect on the results of this vote. Board Recommendation OUR